Cite Filings / CCCC / 0001628280-25-049854

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

C4 Therapeutics, Inc. Filed 2025-11-06 Acc 0001628280-25-049854

Documents 1

10-Q Quarterly Report , cccc-20250930.htm

Around this filing

2026-05-12 10-Q Quarterly Report
2025-11-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-06 10-Q Quarterly Report
2025-11-06 8-K Results of operations
2025-10-30 4 Chief Scientific Officer gave up 5,644 shares (to pay taxes)
2025-08-07 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading cccc-20250930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…